- Home
- ATOS vs IVCA Comparison
ATOS vs IVCA Comparison
Compare ATOS & IVCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- IVCA
- Stock Information
- Founded
- ATOS 2009
- IVCA 2021
- Country
- ATOS United States
- IVCA Cayman Islands
- Employees
- ATOS 10
- IVCA N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- IVCA Blank Checks
- Sector
- ATOS Health Care
- IVCA Finance
- Exchange
- ATOS Nasdaq
- IVCA Nasdaq
- Market Cap
- ATOS 114.5M
- IVCA 93.8M
- IPO Year
- ATOS 2012
- IVCA 2022
- Fundamental
- Price
- ATOS $0.96
- IVCA $11.85
- Analyst Decision
- ATOS Strong Buy
- IVCA
- Analyst Count
- ATOS 3
- IVCA 0
- Target Price
- ATOS $7.00
- IVCA N/A
- AVG Volume (30 Days)
- ATOS 826.7K
- IVCA 3.2K
- Earning Date
- ATOS 11-12-2024
- IVCA 01-01-0001
- Dividend Yield
- ATOS N/A
- IVCA N/A
- EPS Growth
- ATOS N/A
- IVCA N/A
- EPS
- ATOS N/A
- IVCA 0.26
- Revenue
- ATOS N/A
- IVCA N/A
- Revenue This Year
- ATOS N/A
- IVCA N/A
- Revenue Next Year
- ATOS N/A
- IVCA N/A
- P/E Ratio
- ATOS N/A
- IVCA $45.99
- Revenue Growth
- ATOS N/A
- IVCA N/A
- 52 Week Low
- ATOS $0.77
- IVCA $11.07
- 52 Week High
- ATOS $2.31
- IVCA $12.37
- Technical
- Relative Strength Index (RSI)
- ATOS 39.54
- IVCA 54.79
- Support Level
- ATOS $0.81
- IVCA $11.76
- Resistance Level
- ATOS $0.94
- IVCA $12.03
- Average True Range (ATR)
- ATOS 0.05
- IVCA 0.05
- MACD
- ATOS 0.01
- IVCA 0.00
- Stochastic Oscillator
- ATOS 39.13
- IVCA 33.33
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About IVCA Investcorp India Acquisition Corp.
Investcorp AI Acquisition Corp is a blank check company.